Skip to main content
Log in

Evidence Relating Sodium Intake to Blood Pressure and CVD

  • Global Cardiovascular Health (SC Smith, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Sodium is an essential nutrient, mostly ingested as salt (sodium chloride). Average sodium intake ranges from 3 to 6 g per day (7.5–15 g/day of salt) in most countries, with regional variations. Increasing levels of sodium intake have a positive association with higher blood pressure. Randomized controlled trials report a reduction in blood pressure with reducing sodium intake from moderate to low levels, which is the evidence that forms the basis for international guidelines recommending all people consume less than 2.0 g of sodium per day. However, no randomized trials have demonstrated that reducing sodium leads to a reduction in cardiovascular disease (CVD). In their absence, the next option is to examine the association between sodium consumption and CVD in prospective cohort studies. Several recent prospective cohort studies have indicated that while high intake of sodium (>6 g/d) is associated with higher risk of CVD compared to those with moderate intake (3 to 5 g/d), lower intake (<3 g/day) is also associated with a higher risk (despite lower blood pressure levels). However, most of these studies were conducted in populations at increased risk of cardiovascular disease. Current epidemiologic evidence supports that an optimal level of sodium intake is in the range of about 3–5 g/day, as this range is associated with lowest risk of CVD in prospective cohort studies. Randomized controlled trials, comparing the effect of low sodium intake to moderate intake on incidence of cardiovascular events and mortality, are required to truly define optimal intake range.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as • Of importance

  1. Kotchen TA, Cowley Jr AW, Frohlich ED. Salt in health and disease—a delicate balance. N Engl J Med. 2013;368:1229–37.

    Article  PubMed  CAS  Google Scholar 

  2. O’Donnell MJ, Mente A, Smyth A, Yusuf S. Salt intake and cardiovascular disease: why are the data inconsistent? Eur Heart J. 2013;34:1034–40.

    Article  PubMed  Google Scholar 

  3. World Health Organisation. Diet, nutrition and the prevention of chronic diseases. Report of the Joint WHO/FAO Expert Consultation. Geneva: World Health Organisation; 2003. (WHO Technical Report Series, No 916).

  4. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:f1326.

    Article  PubMed  Google Scholar 

  5. Strom BL, Anderson CA, Ix JH. Sodium reduction in populations: insights from the Institute of Medicine committee. JAMA. 2013;310(1):31–2. Institute of Medicine report stating that there was insufficient evidence to provide a recommendation on optimal range of sodium intake for cardiovascular health.

    Article  PubMed  CAS  Google Scholar 

  6. Guideline: sodium intake for adults and children. World Health Organization. 2012. ISBN 978 92 4 150483 6.

  7. Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126:2880–9.

    Article  PubMed  CAS  Google Scholar 

  8. Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995;25:1144–52.

    Article  PubMed  CAS  Google Scholar 

  9. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerova J, Richart T, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011;305:1777–85. Study reported an increased risk with low urinary sodium excretion.

    Article  PubMed  CAS  Google Scholar 

  10. Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care. 2011;34:861–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  11. Ekinci EI, Clarke S, Thomas MC, Moran JL, Cheong K, MacIsaac RJ, et al. Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care. 2011;34:703–9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. O’Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306:2229–38. Study reported a J-shaped association between urinary sodium excretion and cardiovascular events and mortality.

    PubMed  Google Scholar 

  13. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev. 2011;11:CD004022.

  14. Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol. 2009;38:791–813.

    Article  PubMed  Google Scholar 

  15. Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol. 1993;20:7–14.

    Article  PubMed  CAS  Google Scholar 

  16. Shimazu T, Kuriyama S, Hozawa A, Ohmori K, Sato Y, Nakaya N, et al. Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study. Int J Epidemiol. 2007;36:600–9.

    Article  PubMed  Google Scholar 

  17. Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, et al. Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation. 2008;118:1929–37.

    Article  PubMed  CAS  Google Scholar 

  18. O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112–23.

    Article  PubMed  Google Scholar 

  19. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659–69.

    Article  PubMed  CAS  Google Scholar 

  20. Morris Jr RC, Schmidlin O, Frassetto LA, Sebastian A. Relationship and interaction between sodium and potassium. J Am Coll Nutr. 2006;25:262S–70S.

    Article  PubMed  CAS  Google Scholar 

  21. Khaw KT, Barrett-Connor E. Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med. 1987;316:235–40.

    Article  PubMed  CAS  Google Scholar 

  22. Bazzano LA, He J, Ogden LG, Loria C, Vupputuri S, Myers L, et al. Dietary potassium intake and risk of stroke in US men and women: National Health and Nutrition Examination Survey I epidemiologic follow-up study. Stroke. 2001;32:1473–80.

    Article  PubMed  CAS  Google Scholar 

  23. Powles J, Fahimi S, Micha R, Khatibzadeh S, Shi P, Ezzati M, et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open. 2013;3:e003733.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kempner W. Treatment of hypertensive vascular disease with rice diet. Am J Med. 1948;4:545–77.

    Article  PubMed  CAS  Google Scholar 

  25. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761–70.

    Article  PubMed  CAS  Google Scholar 

  26. Frost CD, Law MR, Wald NJ. By how much does dietary salt reduction lower blood pressure? II–Analysis of observational data within populations. BMJ. 1991;302:815–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  27. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ. 1988;297:319–28.

  28. Tunstall-Pedoe H, Woodward M, Tavendale R, A’Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ. 1997;315(7110):722–9.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  29. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3–10.

    Article  PubMed  CAS  Google Scholar 

  30. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med. 1997;157:657–67.

  31. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger Jr WH, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998;279:839–46.

    Article  PubMed  CAS  Google Scholar 

  32. He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346:f1325.

    Article  PubMed  Google Scholar 

  33. Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, et al. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med. 1972;286:441–9.

    Article  PubMed  CAS  Google Scholar 

  34. Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, et al. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol. 2009;103:93–102.

    Article  PubMed  CAS  Google Scholar 

  35. Alderman MH, Cohen HW. Dietary sodium intake and cardiovascular mortality: controversy resolved? Curr Hypertens Rep. 2012;14:193–201.

    Article  PubMed  CAS  Google Scholar 

  36. Heaney RP. Sodium: how and how not to set a nutrient intake recommendation. Am J Hypertens. 2013;26:1194–7.

    Article  PubMed  Google Scholar 

  37. Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008;359:1225–37.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  38. Cushman WC, Evans GW, Byington RP, Goff Jr DC, Grimm Jr RH, Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.

    Article  PubMed  Google Scholar 

  39. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21:875–86.

    Article  PubMed  CAS  Google Scholar 

  40. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145–53.

    Article  PubMed  CAS  Google Scholar 

  41. Alderman MH. Reducing dietary sodium: the case for caution. JAMA. 2010;303:448–9.

    Article  PubMed  CAS  Google Scholar 

  42. Campbell N, Correa-Rotter R, Neal B, Cappuccio FP. New evidence relating to the health impact of reducing salt intake. Nutr Metab Cardiovasc Dis. 2011;21:617–9.

    Article  PubMed  CAS  Google Scholar 

  43. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, et al. Guidelines for the management of chronic kidney disease. CMAJ. 2008;179:1154–62.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Institute of Medicine. Dietary reference intakes. Washington, DC: Institute of Medicine, National Academies Press; 2006.

    Google Scholar 

  45. Michell AR. Physiological aspects of the requirement for sodium in mammals. Nutr Res Rev. 1989;2:149–60.

    Article  PubMed  CAS  Google Scholar 

  46. Whelton PK. Urinary sodium and cardiovascular disease risk: informing guidelines for sodium consumption. JAMA. 2011;306:2262–4.

    Article  PubMed  CAS  Google Scholar 

  47. Mancilha-Carvalho JJ, de Oliveira R, Esposito RJ. Blood pressure and electrolyte excretion in the Yanomamo Indians, an isolated population. J Hum Hypertens. 1989;3:309–14.

    PubMed  CAS  Google Scholar 

  48. Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a “no-salt” culture. Circulation. 1975;52:146–51.

    Article  PubMed  CAS  Google Scholar 

  49. Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, et al. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation. 2011;123:1138–43.

    Article  PubMed  Google Scholar 

  50. He FJ, MacGregor GA. Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis. 2010;52:363–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Andrew Mente has a pending grant support from the Canadian Institutes of Health Research.

Compliance with Ethics Guidelines

Conflict of Interest

Martin O’Donnell has received a grant support from Boehringer-Ingelheim, AstraZeneca and MSD, and has received payment for lectures including service on speakers’ bureaus from Boehringer-Ingelheim and Sanofi-Aventis.

Andrew Mente declares that he has no conflict of interest.

Salim Yusuf has received a grant support from Boehringer-Ingelheim, Servier, GlaxoSmithKline, King Pharma and AstraZeneca, and he has received payment for lectures including service on speakers’ bureaus from Boehringer-Ingelheim, Sanofi, Servier, GlaxoSmithKline, King Pharma and AstraZeneca.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin O’Donnell.

Additional information

This article is part of the Topical Collection on Global Cardiovascular Health

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Donnell, M., Mente, A. & Yusuf, S. Evidence Relating Sodium Intake to Blood Pressure and CVD. Curr Cardiol Rep 16, 529 (2014). https://doi.org/10.1007/s11886-014-0529-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-014-0529-9

Keywords

Navigation